321P Results of an open-label, single-arm phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second-line therapy in patients with cholangiocarcinoma (TRITICC).
Saved in:
| Title: | 321P Results of an open-label, single-arm phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second-line therapy in patients with cholangiocarcinoma (TRITICC). |
|---|---|
| Authors: | Roderburg, C.1 (AUTHOR), Gonzalez Carmona, M.A.2 (AUTHOR), Berres, M-L.3 (AUTHOR), Modest, D.P.4 (AUTHOR), Mohr, R.5 (AUTHOR), Wree, A.6 (AUTHOR), Venerito, M.7 (AUTHOR), Keitel, V.8 (AUTHOR), Waldschmidt, D.T.9 (AUTHOR), Lüdde, T.10 (AUTHOR), Kehmann, L.11 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 1, Vol. 36, pS125-S125. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
